Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Rice

Showing results (211-220 of 238) with videos related to

Pageof 24
Sort By:
The Annals of Thoracic Surgery|April 20, 2023
Gastric Extent of Tumor Predicts Peritoneal Metastasis in Siewert II AdenocarcinomaKyle G Mitchell, Erin M Bayley, Naruhiko Ikoma, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 4, 2020
Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapyErin M Corsini, Wai Chin Foo, Kyle G Mitchell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 25, 2019
The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research FoundationDaniel R Gomez, Andreas Rimner, Charles B Simone, et al.
The American Journal of Gastroenterology|July 6, 2004
Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resectionBanke Agarwal, Stephen Swisher, Jaffer Ajani, et al.
Oncology|March 14, 2015
Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical ImplicationsNastaran Neishaboori, Roopma Wadhwa, Graciela M Nogueras-González, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2016
A Nomogram to Predict Distant Metastases After Multimodality Therapy for Patients With Localized Esophageal CancerKazuki Sudo, Xuemei Wang, Lianchun Xiao, et al.
Oncology|April 30, 2018
Actionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large CohortElena Elimova, Xuemei Wang, Wei Qiao, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 10, 2023
Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancerHope Feldman, Boris Sepesi, Cheuk H Leung, et al.
The Annals of Thoracic Surgery|May 19, 2019
Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III AdenocarcinomaKyle G Mitchell, Naruhiko Ikoma, David B Nelson, et al.
Journal of Thoracic Disease|April 11, 2020
Immune regulatory markers of lepidic-pattern adenocarcinomas presenting as ground glass opacitiesDavid B Nelson, Kyle G Mitchell, Jing Wang, et al.
Pageof 24

Showing results (211-220 of 238) with videos related to

Sort By:
Pageof 24
The Annals of Thoracic Surgery|April 20, 2023
Gastric Extent of Tumor Predicts Peritoneal Metastasis in Siewert II AdenocarcinomaKyle G Mitchell, Erin M Bayley, Naruhiko Ikoma, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 4, 2020
Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapyErin M Corsini, Wai Chin Foo, Kyle G Mitchell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 25, 2019
The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research FoundationDaniel R Gomez, Andreas Rimner, Charles B Simone, et al.
The American Journal of Gastroenterology|July 6, 2004
Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resectionBanke Agarwal, Stephen Swisher, Jaffer Ajani, et al.
Oncology|March 14, 2015
Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical ImplicationsNastaran Neishaboori, Roopma Wadhwa, Graciela M Nogueras-González, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2016
A Nomogram to Predict Distant Metastases After Multimodality Therapy for Patients With Localized Esophageal CancerKazuki Sudo, Xuemei Wang, Lianchun Xiao, et al.
Oncology|April 30, 2018
Actionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large CohortElena Elimova, Xuemei Wang, Wei Qiao, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 10, 2023
Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancerHope Feldman, Boris Sepesi, Cheuk H Leung, et al.
The Annals of Thoracic Surgery|May 19, 2019
Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III AdenocarcinomaKyle G Mitchell, Naruhiko Ikoma, David B Nelson, et al.
Journal of Thoracic Disease|April 11, 2020
Immune regulatory markers of lepidic-pattern adenocarcinomas presenting as ground glass opacitiesDavid B Nelson, Kyle G Mitchell, Jing Wang, et al.
Pageof 24